iTeos Therapeutics, Inc. (ITOS)
10.15
+0.02 (0.20%)
Inactive · Last trade price on Aug 28, 2025
iTeos Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -202.41 | -134.41 | -112.64 | 96.65 | 214.52 | -38.03 |
Depreciation & Amortization | 1.29 | 1.24 | 0.9 | 0.8 | 0.6 | 0.54 |
Stock-Based Compensation | 27.13 | 29.94 | 27.02 | 21.56 | 13.79 | 4.29 |
Other Operating Activities | -12.11 | -13.59 | -10.23 | -1.72 | 0.01 | -1.3 |
Change in Accounts Payable | -5.13 | -2.45 | 3.04 | 2.76 | 2.28 | 1.68 |
Change in Unearned Revenue | 34.71 | -0.57 | -11.77 | -267.23 | 277.65 | 1.79 |
Change in Income Taxes | 4.4 | 4.44 | -4.93 | 6.11 | -7.54 | - |
Change in Other Net Operating Assets | 44.06 | 17.22 | 4.87 | 29.87 | 11.83 | 5.87 |
Operating Cash Flow | -108.06 | -98.18 | -103.76 | -111.19 | 513.14 | -25.18 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -0.63 | -1.63 | -2.97 | -0.94 | -1.18 | -0.36 |
Investment in Securities | 57.45 | -129.49 | 75.72 | -445 | - | - |
Other Investing Activities | -0.05 | -0.03 | -0.1 | -0.12 | -0.06 | -0.02 |
Investing Cash Flow | 56.77 | -131.15 | 72.66 | -446.06 | -1.24 | -0.38 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Issuance of Common Stock | 4.85 | 122.72 | 1.11 | 0.93 | 2.94 | 214.32 |
Other Financing Activities | -0.48 | -0.48 | - | 1.06 | 0.72 | 0.67 |
Financing Cash Flow | 4.37 | 122.24 | 1.11 | 1.98 | 3.66 | 340.34 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | 3.66 | -1.93 | -3.6 | -8.53 | -3.18 | 1.68 |
Net Cash Flow | -43.26 | -109.02 | -33.59 | -563.8 | 512.38 | 316.46 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -108.69 | -99.81 | -106.72 | -112.13 | 511.96 | -25.53 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | -285.18% | -847.34% | -41.90% | 148.49% | - |
Free Cash Flow Per Share | -2.51 | -2.47 | -2.98 | -2.97 | 13.55 | -1.69 |
Levered Free Cash Flow | -22.14 | -64.35 | -73.28 | -150.04 | 431.68 | -18.83 |
Unlevered Free Cash Flow | -22.14 | -64.35 | -73.28 | -150.04 | 431.68 | -18.83 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Income Tax Paid | 2.41 | 4.03 | 6.82 | 22.82 | 32.02 | 0.11 |
Change in Working Capital | 78.03 | 18.65 | -8.8 | -228.49 | 284.21 | 9.33 |